OnKure Therapeutics (OKUR) Cash & Equivalents (2020 - 2026)
OnKure Therapeutics' Cash & Equivalents came in at $166.5 million for Q2 2026, up 99.6% from $83.4 million a year earlier but down 13.3% from the prior quarter.
Powered by 
Analysis
OnKure Therapeutics (OKUR) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, OnKure Therapeutics' Cash & Equivalents was $59.1 million, down 46.7% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 2.0% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $110.8 million in FY2024 (+270.6%), $29.9 million in FY2023 (+50.0%), $19.93 million in FY2022 (-84.0%) and $124.66 million in FY2021 (+132.5%).
- The five-year range for quarterly Cash & Equivalents is $9.08 million (Q2 2023) to $192.11 million (Q1 2026).
- Year-over-year, Cash & Equivalents increased in seven of the last eight quarters, with growth averaging 170.2%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2024 (growth of 417.1%), and the weakest in Q2 2023 (a decline of 92.3%).
- Business Quant data shows OKUR's Cash & Equivalents at $192.11 million (Q1 2026), $59.1 million (Q4 2025) and $70.33 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,127.89 Bn | 1,096.47 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.11 Bn | 554.97 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.80 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.24 Bn | 312.62 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 290.13 Bn | 254.12 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.05 Bn | 238.74 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.87 Bn | 193.27 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.91 Bn | 169.11 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.28 Bn | 117.93 Bn | 10.94 Bn | 976.00 Mn |
| 10 | OnKure Therapeutics | 126.67 Mn | -371.26 Mn | - | 166.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 166.50 Mn |
| Mar 31, 2026 | 192.11 Mn |
| Dec 31, 2025 | 59.10 Mn |
| Sep 30, 2025 | 70.33 Mn |
| Jun 30, 2025 | 83.40 Mn |
| Mar 31, 2025 | 96.70 Mn |
| Dec 31, 2024 | 110.80 Mn |
| Sep 30, 2024 | 60.69 Mn |
| Jun 30, 2024 | 35.97 Mn |
| Mar 31, 2024 | 20.38 Mn |
| Dec 31, 2023 | 29.90 Mn |
| Sep 30, 2023 | 11.74 Mn |
| Jun 30, 2023 | 9.08 Mn |
| Mar 31, 2023 | 30.40 Mn |
| Dec 31, 2022 | 19.93 Mn |
| Sep 30, 2022 | 62.13 Mn |
| Jun 30, 2022 | 118.26 Mn |
| Mar 31, 2022 | 121.09 Mn |
| Dec 31, 2021 | 124.66 Mn |
| Sep 30, 2021 | 126.41 Mn |
API Access
OnKure Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OKUR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "OKUR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OKUR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();